Muscle wasting in kidney disease: Let's get physical.
Ikizler
T Alp
TA
Himmelfarb
Jonathan
J
D045930:Anabolic Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D005080:Exercise Test; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D009133:Muscular Atrophy / Q000628:therapy*; D009142:Musculoskeletal Physiological Phenomena / Q000187:drug effects; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D013997:Time Factors; D016896:Treatment Outcome
D045930:Anabolic Agents; D009277:Nandrolone; D000077603:Nandrolone Decanoate